Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Model Detects Hidden Diabetes Risk by Reading Glucose Spikes

By HospiMedica International staff writers
Posted on 05 Aug 2025

Clinicians often rely on the HbA1c test to diagnose pre-diabetes and type 2 diabetes, as it provides a snapshot of average blood glucose over several months. More...

However, this test cannot predict who is most at risk of progressing from a healthy state to pre-diabetes, or from pre-diabetes to diabetes. While some fluctuations in blood sugar are normal—particularly after eating—frequent or exaggerated glucose spikes may indicate an inability to regulate sugar effectively. In at-risk individuals, these spikes may become more pronounced or resolve more slowly, often before traditional tests like HbA1c detect any abnormalities. Researchers have now developed a new solution that uses wearable sensors and artificial intelligence (AI) to detect early metabolic changes and flag individuals with a heightened risk of developing diabetes.

The new model, developed by researchers at Scripps Research (La Jolla, CA, USA), uses continuous glucose monitor (CGM) data alongside gut microbiome, diet, physical activity and genetic information to flag early signs of diabetes risk missed by standard HbA1c tests. The researchers used data from a multi-year, digital research program called the PRediction Of Glycemic RESponse Study, or PROGRESS, to train the AI model to distinguish people with type 2 diabetes from healthy individuals. The study enrolled more than 1,000 remote participants across the U.S. using social media outreach. The trial included individuals with pre-diabetes, type 2 diabetes, and healthy glucose regulation. For ten days, participants wore Dexcom G6 CGMs, tracked their food intake and physical activity, and submitted blood, saliva, and stool samples. Researchers also reviewed participants’ electronic health records. The study showed that tracking day-to-day dynamics provides a much more detailed view of a person’s metabolic health, and might help identify trouble earlier.

The AI model developed in this study examined patterns such as how long glucose spikes took to normalize and overnight glucose behavior to distinguish individuals on a faster path to diabetes. To validate the model, researchers trained it to differentiate between individuals with type 2 diabetes and those without the disease. One of the clearest indicators of diabetes risk was the time taken for blood sugar to return to normal after a spike—diabetic individuals often required over 100 minutes. In contrast, healthier individuals returned to baseline more quickly. The study also found that people with a more diverse gut microbiome and higher activity level tended to have better glucose control, while a higher resting heart rate was linked to diabetes. The results, published in Nature Medicine, show that the model revealed that even among people with similar HbA1c scores, some showed high metabolic risk while others resembled healthy individuals. This AI-powered approach could help tailor early interventions, guide lifestyle changes, and eventually be adopted for personal use in CGM-based monitoring. Researchers are continuing to follow participants to assess long-term predictive accuracy and expand clinical utility.

“Ultimately, this is about giving people more insight and control. Diabetes doesn’t just appear one day—it builds slowly, and we now have the tools to detect it earlier and intervene smarter,” said co-senior author Giorgio Quer, the director of artificial intelligence and assistant professor of Digital Medicine at Scripps Research.

Related Links:
Scripps Research


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.